Results: 4

Pharmacovigilance of thalidomide in the Brazilian Health System and patient safety

In Brazil, thalidomide is manufactured by a public laboratory, distributed by the Unified Health System (SUS), and regulated by the National Health Surveillance Agency (Anvisa). Despite the concerns regarding the adverse effects of thalidomide, few drug utilization studies have been conducted to describe...

Assessing the overall medication use by elderly people in a Brazilian hospital using the start/stopp criteria version 2

To estimate the frequency of the use of medicines listed in the Screening Tool to Alert Doctors to the Right Treatment (START) and Screening Tool of Older Person's Prescriptions (STOPP) criteria version 2 among the elderly. A cross-sectional study was conducted on elderly who were attended in medical cli...

Pharmacoepidemiological profile and polypharmacy indicators in elderly outpatients

Braz. j. pharm. sci; 49 (3), 2013
This cross-sectional study was carried out with 1000 elderly outpatients assisted by a Basic Health District Unit (UBDS) from the Brazilian Public Health System (SUS) in the municipality of Ribeirão Preto. We analyzed the clinical, socioeconomic and pharmacoepidemiological profile of the elderly patient...

Avaliação do Qualisus na Bahia

A presente dissertação tem como objeto de estudo a avaliação do Programa QualiSUS no Estado da Bahia, conforme seus pilares referenciados na Portaria 3.125 de 07 de dezembro de 2006, que institui o Programa. Está fundamentada na trilogia de Donabedian: Estrutura, Processo e Resultado. Trata-se de um...